日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Digital dating engagement among young users: gender differences in Tinder use motivations and associations with sexual desire but not self-esteem

年轻用户参与数字约会的情况:Tinder 使用动机中的性别差异及其与性欲而非自尊的关联

Morlat, Pantxika Victoire; Limniou, Maria; Alison, Laurence

Understanding "Childhood Poly-Victimization" to help uncover abuse during child investigative interviewing: a systematic review

了解“儿童多重受害”有助于在儿童调查访谈中发现虐待行为:一项系统性综述

Morlat, Pantxika Victoire; Alison, Laurence

HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015

欧洲艾滋病毒感染者中艾滋病毒复制与结核病风险:一项多队列分析,1983-2015年

Atkinson, Andrew; Kraus, David; Banholzer, Nicolas; Miro, Jose M; Reiss, Peter; Kirk, Ole; Mussini, Cristina; Morlat, Philippe; Podlekareva, Daria; Grant, Alison D; Sabin, Caroline; van der Valk, Marc; Le Moing, Vincent; Meyer, Laurence; Seng, Remonie; Castagna, Antonella; Obel, Niels; Antoniadou, Anastasia; Salmon, Dominique; Zwahlen, Marcel; Egger, Matthias; de Wit, Stephane; Furrer, Hansjakob; Fenner, Lukas

Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE

在病毒学抑制的人类免疫缺陷病毒感染者中停止原发性肺孢子菌肺炎预防:COHERE 研究中一项实用性试验的模拟

Atkinson, Andrew; Zwahlen, Marcel; Barger, Diana; d'Arminio Monforte, Antonella; De Wit, Stephane; Ghosn, Jade; Girardi, Enrico; Svedhem, Veronica; Morlat, Philippe; Mussini, Cristina; Noguera-Julian, Antoni; Stephan, Christoph; Touloumi, Giota; Kirk, Ole; Mocroft, Amanda; Reiss, Peter; Miro, Jose M; Carpenter, James R; Furrer, Hansjakob

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

对于来自欧洲、接受抗逆转录病毒疗法(ART)且病毒载量受到抑制、CD4细胞计数大于100个/µL的HIV感染成人,无需进行卡氏肺囊虫肺炎的二级预防。

Atkinson, Andrew; Miro, Jose M; Mocroft, Amanda; Reiss, Peter; Kirk, Ole; Morlat, Philippe; Ghosn, Jade; Stephan, Christoph; Mussini, Cristina; Antoniadou, Anastasia; Doerholt, Katja; Girardi, Enrico; De Wit, Stéphane; Kraus, David; Zwahlen, Marcel; Furrer, Hansjakob

The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study

免疫抑制对人类免疫缺陷病毒感染者慢性肾脏病的影响:D:A:D 研究

Ryom, Lene; Lundgren, Jens D; Reiss, Peter; Ross, Mike; Kirk, Ole; Fux, Christophe A; Morlat, Phillipe; Fontas, Eric; Smith, Colette; De Wit, Stephane; d'Arminio Monforte, Antonella; El Sadr, Wafaa; Hatleberg, Camilla; Phillips, Andrew; Sabin, Caroline; Law, Matthew; Mocroft, Amanda

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial

一项针对 HIV-1 感染者的初免加强免疫治疗策略的随机安慰剂对照疗效研究:VRI02 ANRS 149 LIGHT II 期试验

Lévy, Y; Lacabaratz, C; Lhomme, E; Wiedemann, A; Bauduin, C; Fenwick, C; Foucat, E; Surenaud, M; Guillaumat, L; Boilet, V; Rieux, V; Bouchaud, O; Girard, P-M; Molina, J-M; Morlat, P; Hocqueloux, L; Richert, L; Pantaleo, G; Lelièvre, J D; Thiébaut, R

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)

HIV/HCV合并感染患者的咖啡摄入量与神经认知功能(ANRS CO13 HEPAVIH)

Antwerpes, Saskia; Protopopescu, Camelia; Morlat, Philippe; Marcellin, Fabienne; Wittkop, Linda; Di Beo, Vincent; Salmon-Céron, Dominique; Sogni, Philippe; Michel, Laurent; Carrieri, Maria Patrizia; The Anrs Co Hepavih Study Group

ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study)

接受抗逆转录病毒疗法的患者对HFVAC肽(一种潜在的HIV-1治疗性疫苗)表现出适应性免疫反应(Provir/Latitude45研究)

Fleury, Hervé; Caldato, Sabrina; Recordon-Pinson, Patricia; Thebault, Patricia; Guidicelli, Gwenda-Line; Hessamfar, Mojgan; Morlat, Philippe; Bonnet, Fabrice; Visentin, Jonathan

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

达芦那韦-利托那韦联合拉替拉韦或富马酸替诺福韦酯-恩曲他滨进行初始治疗后,身体成分和脂肪因子发生的变化:NEAT001/ANRS143随机试验的子研究

Bernardino, Jose I; Mocroft, Amanda; Wallet, Cedrick; de Wit, Stéphane; Katlama, Christine; Reiss, Peter; Mallon, Patrick W; Richert, Laura; Molina, Jean-Michel; Knobel, Hernando; Morlat, Philippe; Babiker, Abdel; Pozniac, Anton; Raffi, Francois; Arribas, Jose R